Samsung Biologics Co.,Ltd. (KRX: 207940)

Samsung Biologics Co.,Ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	73,736,264	54,092,240	58,433,854	59,746,995	54,652,290	28,649,445
Market Cap Growth	-2.28%	-7.43%	-2.20%	9.32%	90.76%	12.03%
Enterprise Value	73,849,220	54,470,492	57,778,382	59,669,232	54,358,190	28,694,172
Last Close Price	1036000.00	760000.00	821000.00	893509.47	817318.74	428449.17
PE Ratio	71.70	63.07	71.82	150.20	224.41	139.71
PS Ratio	17.51	14.64	19.47	38.10	46.92	40.83
PB Ratio	7.14	5.50	6.50	11.97	11.88	6.58
P/FCF Ratio	69.29	80.60	-15410.21	1235.91	875.48	-156.83
P/OCF Ratio	31.29	32.46	61.31	131.43	270.44	2821.60
EV/Sales Ratio	17.54	14.74	19.25	38.05	46.67	40.90
EV/EBITDA Ratio	38.95	33.97	44.72	85.35	124.54	127.74
EV/EBIT Ratio	55.78	48.91	58.74	111.05	185.66	312.77
EV/FCF Ratio	69.39	81.16	-15237.35	1234.30	870.77	-157.07
Debt / Equity Ratio	0.16	0.19	0.28	0.26	0.17	0.15
Debt / EBITDA Ratio	0.89	1.19	1.95	1.85	1.80	2.91
Debt / FCF Ratio	1.58	2.84	-663.00	26.74	12.57	-3.58
Asset Turnover	0.26	0.23	0.24	0.22	0.19	0.12
Inventory Turnover	0.80	0.76	0.91	1.02	1.37	1.35
Quick Ratio	0.39	0.49	0.76	1.24	1.45	1.00
Current Ratio	1.35	1.33	1.54	2.55	2.97	1.96
Return on Equity (ROE)	10.47%	9.12%	11.42%	8.21%	5.38%	4.77%
Return on Assets (ROA)	5.17%	4.27%	5.01%	4.67%	2.97%	0.96%
Return on Capital (ROIC)	6.99%	5.99%	6.91%	5.76%	3.52%	1.14%
Earnings Yield	1.39%	1.59%	1.37%	0.66%	0.44%	0.71%
FCF Yield	1.44%	1.24%	-0.01%	0.08%	0.11%	-0.64%
Buyback Yield / Dilution	0.01%	-1.95%	-5.51%	-	-	-
Total Shareholder Return	0.01%	-1.95%	-5.51%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.